Clinical Trials Logo
  1. Home
  2. Type 2 Diabetes
  3. NCT01787214

Walnuts and Glucose Variability

Type-2 Diabetes Clinical Trial

Official title:
The Effect of Walnuts on Glucose Variability in Adults With Type-2 Diabetes Mellitus: a Dose-response Metabolic Feeding Study

Clinical Trial Summary

Persons with type 2 diabetes mellitus (T2DM) have swings in their blood sugar levels that may lead to a higher risk of developing heart disease. An important part of diabetes management involves eating a diet to prevent large swings in blood sugar levels. Walnuts contain fat, protein and fiber that may reduce the swings in blood sugar. The purpose of this study is to compare the effects of a walnut-free American Diabetes Association (ADA) diet versus 2 levels of walnut-enriched ADA diets on blood sugar swings. Eighteen male and female adults with T2DM will participate in the study. Subjects will be randomized to consume an ADA diet with or without walnuts for 3 consecutive days every other week. Subjects must test their blood sugar twice daily and wear a continuous glucose monitor during the three 72-hour study periods. Subjects will be between 40 and 70 years of age and will be recruited from the surrounding community using flyers and public service announcements. Consent will take place in the Department of Nutrition at Loma Linda University by the study investigators. In total, subject participation will last 5 weeks and all meals will be provided during the 3 study periods.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01787214
Study type Interventional
Source Loma Linda University
Contact
Status Terminated
Phase N/A
Start date June 2013
Completion date September 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT02797392 - Feasibility of a Preventive Program Against Lifestyle Related Diseases N/A
Completed NCT01264523 - Nutritional Intervention With Moderately High-protein, Low-glycemic Load Products in Type-2 Diabetes Patients N/A
Completed NCT04105608 - GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients. N/A
Completed NCT03624803 - DAPA - Egypt Study
Completed NCT01715428 - Liraglutide and Cardio-Metabolic Risk Markers N/A
Completed NCT01884714 - Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study N/A
Completed NCT00567047 - Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment Phase 1
Completed NCT02191644 - Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 Diabetes Phase 2
Completed NCT01440660 - Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER) N/A
Completed NCT01343589 - Effects of Milk Derived From Mountain-pasture Grazing Cows on Risk Markers of the Metabolic Syndrome Compared to Conventional Danish Milk N/A
Completed NCT00651105 - Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects Phase 3
Completed NCT04330911 - The Effects of Aerobic Exercises on Exercise Capacity in Type-2 Diabetes Mellitus N/A
Completed NCT03269058 - Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes Phase 4
Completed NCT04952948 - Pilates Method on Functional Capacity and Blood Pressure of Elderly Women With Type 2 Diabetes N/A
Completed NCT00478127 - Hepatocyte Growth Factor and Cardiovascular Autonomic Function N/A